최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Molecules and cells, v.44 no.11, 2021년, pp.843 - 850
Lee, Jieun (Department of Biological Sciences, Sookmyung Women's University) , Kim, Youngju (Department of Biological Sciences, Sookmyung Women's University) , Jin, Seonghee (Department of Biological Sciences, Sookmyung Women's University) , Yoo, Heeseung (Department of Biological Sciences, Sookmyung Women's University) , Jeong, Sumin (Department of Biological Sciences, Sookmyung Women's University) , Jeong, Euna (Research Institute of Women's Health, Sookmyung Women's University) , Yoon, Sukjoon (Department of Biological Sciences, Sookmyung Women's University)
The rapid increase in collateral omics and phenotypic data has enabled data-driven studies for the fast discovery of cancer targets and biomarkers. Thus, it is necessary to develop convenient tools for general oncologists and cancer scientists to carry out customized data mining without computationa...
Aran, D., Hu, Z., and Butte, A.J. (2017). xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220.
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A.A., Kim, S., Wilson, C.J., Lehar, J., Kryukov, G.V., Sonkin, D., et al. (2012). The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603-607.
Biswas, A., Haldane, A., Arnold, E., and Levy, R.M. (2019). Epistasis and entrenchment of drug resistance in HIV-1 subtype B. Elife 8, e50524.
Cancer Genome Atlas Research Network, Weinstein, J.N., Collisson, E.A., Mills, G.B., Shaw, K.R., Ozenberger, B.A., Ellrott, K., Shmulevich, I., Sander, C., and Stuart, J.M. (2013). The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113-1120.
Cao, R., Yuan, L., Ma, B., Wang, G., Qiu, W., and Tian, Y. (2020). An EMT-related gene signature for the prognosis of human bladder cancer. J. Cell. Mol. Med. 24, 605-617.
Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Byrne, C.J., Heuer, M.L., Larsson, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404.
Eckstein, M., Strissel, P., Strick, R., Weyerer, V., Wirtz, R., Pfannstiel, C., Wullweber, A., Lange, F., Erben, P., Stoehr, R., et al. (2020). Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy. J. Immunother. Cancer 8, e000162.
Garnett, M.J., Edelman, E.J., Heidorn, S.J., Greenman, C.D., Dastur, A., Lau, K.W., Greninger, P., Thompson, I.R., Luo, X., Soares, J., et al. (2012). Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570-575.
Ghandi, M., Huang, F.W., Jane-Valbuena, J., Kryukov, G.V., Lo, C.C., McDonald, E.R., 3rd, Barretina, J., Gelfand, E.T., Bielski, C.M., Li, H., et al. (2019). Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 569, 503-508.
Guan, N.N., Zhao, Y., Wang, C.C., Li, J.Q., Chen, X., and Piao, X. (2019). Anticancer drug response prediction in cell lines using weighted graph regularized matrix factorization. Mol. Ther. Nucleic Acids 17, 164-174.
He, N., Kim, N., Song, M., Park, C., Kim, S., Park, E.Y., Yim, H.Y., Kim, K., Park, J.H., Kim, K.I., et al. (2014). Integrated analysis of transcriptomes of cancer cell lines and patient samples reveals STK11/LKB1-driven regulation of cAMP phosphodiesterase-4D. Mol. Cancer Ther. 13, 2463-2473.
Hong, Y., Kim, N., Li, C., Jeong, E., and Yoon, S. (2017). Patient sample-oriented analysis of gene expression highlights extracellular signatures in breast cancer progression. Biochem. Biophys. Res. Commun. 487, 307-312.
Iorio, F., Knijnenburg, T.A., Vis, D.J., Bignell, G.R., Menden, M.P., Schubert, M., Aben, N., Goncalves, E., Barthorpe, S., Lightfoot, H., et al. (2016). A landscape of pharmacogenomic interactions in cancer. Cell 166, 740-754.
Jeong, E., Lee, Y., Kim, Y., Lee, J., and Yoon, S. (2020). Analysis of cross-association between mRNA expression and RNAi efficacy for predictive target discovery in colon cancers. Cancers (Basel) 12, 3091.
Kim, N., Yim, H.Y., He, N., Lee, C.J., Kim, J.H., Choi, J.S., Lee, H.S., Kim, S., Jeong, E., Song, M., et al. (2016). Cardiac glycosides display selective efficacy for STK11 mutant lung cancer. Sci. Rep. 6, 29721.
Kitsou, M., Ayiomamitis, G.D., and Zaravinos, A. (2020). High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer. Int. J. Oncol. 57, 237-248.
Li, T., Fu, J., Zeng, Z., Cohen, D., Li, J., Chen, Q., Li, B., and Liu, X.S. (2020). TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48(W1), W509-W514.
Li, W., Wang, H., Ma, Z., Zhang, J., Ou-Yang, W., Qi, Y., and Liu, J. (2019). Multi-omics analysis of microenvironment characteristics and immune escape mechanisms of hepatocellular carcinoma. Front. Oncol. 9, 1019.
Li, Y., Umbach, D.M., Krahn, J.M., Shats, I., Li, X., and Li, L. (2021). Predicting tumor response to drugs based on gene-expression biomarkers of sensitivity learned from cancer cell lines. BMC Genomics 22, 272.
McFarland, J.M., Ho, Z.V., Kugener, G., Dempster, J.M., Montgomery, P.G., Bryan, J.G., Krill-Burger, J.M., Green, T.M., Vazquez, F., Boehm, J.S., et al. (2018). Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration. Nat. Commun. 9, 4610.
Meyers, R.M., Bryan, J.G., McFarland, J.M., Weir, B.A., Sizemore, A.E., Xu, H., Dharia, N.V., Montgomery, P.G., Cowley, G.S., Pantel, S., et al. (2017). Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat. Genet. 49, 1779-1784.
Monks, A., Zhao, Y., Hose, C., Hamed, H., Krushkal, J., Fang, J., Sonkin, D., Palmisano, A., Polley, E.C., Fogli, L.K., et al. (2018). The NCI Transcriptional Pharmacodynamics Workbench: a tool to examine dynamic expression profiling of therapeutic response in the NCI-60 cell line panel. Cancer Res. 78, 6807-6817.
Rhodes, D.R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A., and Chinnaiyan, A.M. (2004). ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1-6.
Shen, Y., Liu, J., Zhang, L., Dong, S., Zhang, J., Liu, Y., Zhou, H., and Dong, W. (2019). Identification of potential biomarkers and survival analysis for head and neck squamous cell carcinoma using bioinformatics strategy: a study based on TCGA and GEO datasets. Biomed Res. Int. 2019, 7376034.
Shi, B., Ding, J., Qi, J., and Gu, Z. (2021). Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap. Int. J. Med. Sci. 18, 2063-2075.
Yang, D., Khan, S., Sun, Y., Hess, K., Shmulevich, I., Sood, A.K., and Zhang, W. (2011). Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA 306, 1557-1565.
Yang, W., Soares, J., Greninger, P., Edelman, E.J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J.A., Thompson, I.R., et al. (2013). Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 41(Database issue), D955-D961.
Zhong, Z., Hong, M., Chen, X., Xi, Y., Xu, Y., Kong, D., Deng, J., Li, Y., Hu, R., Sun, C., et al. (2020). Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. BMC Med. Genomics 13, 57.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.